Skip to main content

Written question asked by Martyn Day (Scottish National Party) on Friday, 23 October 2020, in the House of Commons. It was due for an answer on Monday, 2 November 2020. It was answered by Baroness Prentis of Banbury (Conservative) on Friday, 6 November 2020 on behalf of the Department for Environment, Food and Rural Affairs.


Cannabidiol

Question

To ask the Secretary of State for Environment, Food and Rural Affairs, what steps his Department has taken to review the safety of cannabidiol-containing products sold to consumers.

Answer

Any food product containing Cannabidiol (CBD) is the responsibility of the Food Standards Agency. To bring industry into compliance with the Novel Foods Regulations, in February 2020 the Food Standards Agency announced a deadline of the end of March 2021 for businesses to have validated applications which will be submitted for risk assessment and any subsequent risk management considerations. This process will involve approval based upon dossiers (including safety data), submitted to and reviewed by the Advisory Committee on Novel Food Products.

In addition to this, the Committee on Toxicology has reviewed the available evidence on the safety on CBD in food. Its independent, expert advice was used to help set the current recommendations and consumption limits.

After the deadline any products not linked to a validated application will no longer be allowed to remain on the market and no new products have been allowed on the market since February 2020 without pre-market authorisation. CBD-containing food products are no different to other foods in that they are also subject to all other relevant food laws.

In Scotland, Food Standards Scotland has regulatory responsibility for CBD used in food products. Food Standards Scotland is working with local authorities and other partners to keep the safety of CBD food products currently on the market under review, and to ensure that products stating they contain this ingredient do so.

Cannabis-based products for medicinal use (CBPM) are not consumer products and are regulated separately. CBPMs must comply with the requirements of the Misuse of Drugs Act 1971, Misuse of Drugs Regulations 2001 and Humans Medicines Regulations 2012.


Secondary information

Type
Written question
Reference
108270
Session
2019-21
Subjects
Safety Cannabidiol
Link
View this Written question on www.parliament.uk